Insider filing · LLY
Donald A Zakrowski
SVP, Finance, & CAO
profile →
Eli Lilly and Company
LLY · Healthcare · 118 filings in 24 months
ticker →
Donald A Zakrowski sold $2.4M of Eli Lilly and (LLY)
Executed Aug 10, disclosed Aug 11, 1 day later.
Value, as filed
$2.4M
2,000 sh × $1,185.01
Executed
Aug 10
the trade date, as filed
Disclosed
Aug 11
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DZDonald A Zakrowski (SVP, Finance, & CAO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Eli Lilly and Company (LLY). The largest single filing was $2.4M of LLY (2,000 sh × $1,185.01, as filed), executed Aug 10.
The name
LLYHealthcare · Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Jap…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Donald A Zakrowski in LLY
LLYSALE
Eli Lilly and Company
$1.0M1,000 sh × $1,010.50
Exec Nov 13 2025
Filed Nov 13 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $735K
1,000 sh × $734.93
Exec Aug 28 2025
Filed Aug 28 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $716K
1,000 sh × $716.41
Exec May 27 2025
Filed May 27 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $818K
1,000 sh × $818.24
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $723K
900 sh × $803.38
Exec Nov 8 2024
Filed Nov 8 2024 · 5:30 PM ET